Exhibit 99.1, Zimmer Biomet: A Quiet IR Map as Earnings Season Approaches
In the voice of Matt Levine, with a nod to the ticker ZBH, this look under the SEC’s Exhibit 99.1 reveals how a big-cap medical device maker provisions its public-facing communications ahead of financial results. EPS, earnings surprises, EPS consensus, and revenue forecast are terms you’ll hear more about when the numbers actually drop, but what this document shows is the plumbing behind the newsroom.
Document snapshot
The excerpt is an EX-99.1 exhibit filed with the SEC, embedded in a DFIN ActiveDisclosure HTML document. It carries the usual header metadata—Creation Date, copyright notice, and a markup that indexes it as an exhibit rather than a company update. The visible content is a contact-focused page for Zimmer Biomet, complete with the company’s physical address, website, and two clearly delineated contact groups: Media and Investors.
Crucially, there are no numerical figures here. No EPS. No revenue forecast. No earnings surprise. No EPS consensus. It is, instead, a map of who to call when questions arrive—an investor-relations nerve center rather than a balance sheet. The page anchors Zimmer Biomet’s corporate identity to a familiar place: 345 E. Main St., Warsaw, IN 46580, and the corporate site www.zimmerbiomet.com.
Investor relations contacts at a glance
The document lays out two primary contact streams, neatly separated into Media and Investors, which is telling in itself about how the company wants to shepherd inquiries during a potentially busy earnings cycle.
| Media | Investors |
|---|---|
| Troy Kirkpatrick 614-284-1926 troy.kirkpatrick@zimmerbiomet.com | David DeMartino 646-531-6115 david.demartino@zimmerbiomet.com |
What the exhibit implies about Zimmer Biomet's communications strategy
You don’t need a bankable balance sheet to sense a company’s posture: this Exhibit 99.1 is the newsroom’s front door. It signals a readiness to respond quickly to media inquiries and to coordinate investor outreach when the next earnings release lands. The inclusion of explicit media and investor contacts—plus the physical address and the official website—gives journalists and analysts a clear line of sight to the company’s IR machinery, even before any numbers are published.
Portents for Zimmer Biomet’s sector peers
In healthcare devices, the cadence of disclosures matters as much as the numbers themselves. An Exhibit 99.1 that cleanly delineates media and investor contacts can become a small but meaningful signal: management wants to control the narrative and ensure inquiries are directed to a coherent channel. For peers, this illustrates a robust IR scaffold that can help translate any forthcoming EPS signals—whether a higher or lower EPS, an earnings surprise, or a revised revenue forecast—into a more orderly information flow. It’s not a forecast, but it’s a forecastable process: the path from “we’ve got questions” to “here’s the consistent answer.”
What to watch next
- Upcoming earnings release for ZBH and how the EPS figures line up with consensus expectations.
- Any revisions to the revenue forecast and whether investors push for guidance consistency across the sector.
- Whether the earnings surprise emerges and how the company frames it through IR messaging.
- How peers mirror Zimmer Biomet’s IR setup during the next wave of filings and press material.
Bottom line
This Exhibit 99.1 isn’t a number, it’s a doorway. A well-marked one. It gives the market a predictable route to questions when the actual earnings drop, which is as valuable as a clean set of financials in the chaos of earnings season. For ZBH and its peers, the real signal may be less about the digits that come with EPS and revenue, and more about whether the company can sustain a crisp, credible dialogue with the market—especially when the next earnings surprise risks are higher than usual.